로딩 중…
지수 로딩 중…
지엘팜텍
204840· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩899-0.99%
2026-06-19
Price Chart
지엘팜텍-28.37%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 69.72B KRW |
| Revenue | 36.86B KRW |
| Net Income | -345.5M KRW |
| Total Assets | 48.60B KRW |
| Net Assets | 19.80B KRW |
| Employees | 25 |
| Value | |
| P/B | 3.52x |
| P/S | 1.89x |
| FCF Yield | -6.21% |
| Profitability | |
| ROE | -1.75% |
| ROA | -0.71% |
| Op. Margin | -1.05% |
| Revenue Growth | 20.34% |
| Earnings Growth | -598.48% |
| Financial Health | |
| Debt Ratio | 245.49% |
| Total Debt | 23.42B KRW |
| FCF | -4.33B KRW |
| Cash | 3.02B KRW |
| Current Ratio | 0.95x |
| Performance | |
| 1Y Return | -28.37% |
| 1M Return | -3.75% |
| From 52W High | -33.51% |
| 1Y MDD | -32.95% |
| Trading | |
| Volume | 87,282 shares |
| Foreign Own. | 1.48% |
| Per Share | |
| EPS | -2 KRW |
| BPS | 255 KRW |
Company Info
GL Pharm Tech, established in 2014 and headquartered in Seongnam-si, Gyeonggi-do, is a specialized enterprise in pharmaceutical research and development services and sales & marketing, listed on KOSDAQ in 2014. The company focuses on developing incrementally modified drugs using Drug Delivery System (DDS) technologies like controlled release and drug absorption enhancement. Its consolidated subsidiary, GL Pharma Co., Ltd., possesses hormone drug production facilities, which only a few domestic pharmaceutical companies have, and produces and sells pharmaceuticals, expanding its business into contract manufacturing and sales.